IHCeasy® ARHGEF12/LARG Ready-To-Use IHC Kit
ARHGEF12/LARG Ready-to-use reagent kit for IHC.
Cat no : KHC2981
Synonyms
ARHGEF12, KIAA0382, LARG, Leukemia associated RhoGEF, Leukemia-associated RhoGEF
Validation Data Gallery View All
Product Information
KHC2981 is a ready-to-use IHC kit for staining of ARHGEF12/LARG. The kit provides all reagents, from antigen retrieval to cover slip mounting, that require little to no diluting or handling prior to use. Simply apply the reagents to your sample slide according to the protocol and you're steps away from obtaining high-quality IHC data.
Product name | IHCeasy® ARHGEF12/LARG Ready-To-Use IHC Kit |
Sample type | FFPE tissue |
Assay type | Immunohistochemistry |
Primary antibody type | Rabbit Polyclonal |
Secondary antibody type | Polymer-HRP-Goat anti-Rabbit |
Reactivity | Human |
Kit components
Component | Size | Concentration |
---|---|---|
Antigen Retrieval Buffer | 100 mL | 50× |
Washing Buffer | 100 mL ×2 | 20× |
Blocking Buffer | 5 mL | RTU |
Primary Antibody | 5 mL | RTU |
Secondary Antibody | 5 mL | RTU |
Chromogen Component A | 0.2 mL | RTU |
Chromogen Component B | 4 mL | RTU |
Signal Enhancer | 5 mL | RTU |
Counter Staining Reagent | 5 mL | RTU |
Mounting Media | 5 mL | RTU |
Datasheet | 1 Copy | |
Manual | 1 Copy |
Background Information
LARG, also known as ARHGEF12, is one of three regulator of G protein signalling (RGS) domain-containing RhoGEFs. LARG activates the ROCK pathway downstream of Gα12/13 signaling, leading to cytoskeletal reorganisation. LARG performs this activity either as a homodimer or as a heterodimer with Arhgef11. LARG has been implicated in many diseases, including cancer, heart disease, and in HIV viral replication. LARG is phosphorylated and dephosphorylated during mitosis and that Cdk1 is the mitotic kinase responsible for LARG phosphorylation.
Properties
Storage Instructions | All the reagents are stored at 2-8°C. The kit is stable for 6 months from the date of receipt. |
Synonyms | ARHGEF12, KIAA0382, LARG, Leukemia associated RhoGEF, Leukemia-associated RhoGEF |